Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.52−0.04 (-2.48%)
Close on Nov 18, 2026Market cap $857.01KP/E –Yield –
Universe Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$5.32B. The highest annual figure on record is $1.07B in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$5.32B | – |
| FY2024 | Sep 30, 2024 | -$9.72B | -1005.7% |
| FY2023 | Sep 30, 2023 | $1.07B | – |
| FY2022 | Sep 30, 2022 | -$1.40M | – |
| FY2021 | Sep 30, 2021 | -$2.50M | -141.2% |
| FY2020 | Sep 30, 2020 | $6.06M | -53.8% |
| FY2019 | Sep 30, 2019 | $13.12M | – |
See a number that looks wrong?